BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24893317)

  • 1. Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: an interdisciplinary perspective.
    Larouche E; Hudon C; Goulet S
    Behav Brain Res; 2015 Jan; 276():199-212. PubMed ID: 24893317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mindfulness mechanisms and psychological effects for aMCI patients: A comparison with psychoeducation.
    Larouche E; Hudon C; Goulet S
    Complement Ther Clin Pract; 2019 Feb; 34():93-104. PubMed ID: 30712752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mindfulness and psychoeducation to manage stress in amnestic mild cognitive impairment: A pilot study.
    Chouinard AM; Larouche E; Audet MC; Hudon C; Goulet S
    Aging Ment Health; 2019 Sep; 23(9):1246-1254. PubMed ID: 30406681
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review.
    Blackman J; Swirski M; Clynes J; Harding S; Leng Y; Coulthard E
    J Sleep Res; 2021 Aug; 30(4):e13229. PubMed ID: 33289311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Adults with Mild Cognitive Impairment Build Cognitive Reserve and Learn Mindfulness Meditation? Qualitative Theme Analyses from a Small Pilot Study.
    Wells RE; Kerr C; Dossett ML; Danhauer SC; Sohl SJ; Sachs BC; Feeley JW; Wolkin J; Wall R; Kaptchuk T; Press DZ; Phillips RS; Yeh GY
    J Alzheimers Dis; 2019; 70(3):825-842. PubMed ID: 31282418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment.
    Vasavada MM; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
    J Alzheimers Dis; 2015; 45(3):947-58. PubMed ID: 25633674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
    Buschert VC; Friese U; Teipel SJ; Schneider P; Merensky W; Rujescu D; Möller HJ; Hampel H; Buerger K
    J Alzheimers Dis; 2011; 25(4):679-94. PubMed ID: 21483095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple diffusion indices reveals white matter degeneration in Alzheimer's disease and mild cognitive impairment: a tract-based spatial statistics study.
    Shu N; Wang Z; Qi Z; Li K; He Y
    J Alzheimers Dis; 2011; 26 Suppl 3():275-85. PubMed ID: 21971467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus callosum atrophy associated with the degree of cognitive decline in patients with Alzheimer's dementia or mild cognitive impairment: a meta-analysis of the region of interest structural imaging studies.
    Wang XD; Ren M; Zhu MW; Gao WP; Zhang J; Shen H; Lin ZG; Feng HL; Zhao CJ; Gao K
    J Psychiatr Res; 2015 Apr; 63():10-9. PubMed ID: 25748753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease, dementia, mild cognitive impairment and the menopause: a 'window of opportunity'?
    Davey DA
    Womens Health (Lond); 2013 May; 9(3):279-90. PubMed ID: 23638783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Mindfulness on Persons with Mild Cognitive Impairment: Protocol for a Mixed-Methods Longitudinal Study.
    Wong WP; Hassed C; Chambers R; Coles J
    Front Aging Neurosci; 2016; 8():156. PubMed ID: 27445799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk population.
    Ashton NJ; Hye A; Leckey CA; Jones AR; Gardner A; Elliott C; Wetherell JL; Lenze EJ; Killick R; Marchant NL
    Transl Psychiatry; 2017 Jun; 7(6):e1148. PubMed ID: 28585932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].
    Allegri RF; Russo MJ; Kremer J; Taragano FE; Brusco I; Ollari JA; Serrano CM; Sarasola D; Demey I; Arizaga RL; Bagnati P
    Vertex; 2012; 23(101):5-15. PubMed ID: 22880190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.